BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9509679)

  • 1. Visual field defects in patients with pituitary adenomas.
    Huang WC; Lee LS
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Nov; 60(5):245-51. PubMed ID: 9509679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Predictive Value of Suprasellar Extension for Visual Function Evaluation in Chinese Patients with Nonfunctioning Pituitary Adenoma with Optic Chiasm Compression.
    Gan L; Ma J; Feng F; Wang Y; Cui J; Guo X; Zhang X; You H; Wang Z; Yin Z; Zhong Y; Xing B
    World Neurosurg; 2018 Aug; 116():e960-e967. PubMed ID: 29857216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors for visual dysfunction in nonfunctioning pituitary adenomas - implications for neurosurgical management.
    Schmalisch K; Milian M; Schimitzek T; Lagrèze WA; Honegger J
    Clin Endocrinol (Oxf); 2012 Nov; 77(5):728-34. PubMed ID: 22747829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual Defects in Patients With Pituitary Adenomas: The Myth of Bitemporal Hemianopsia.
    Lee IH; Miller NR; Zan E; Tavares F; Blitz AM; Sung H; Yousem DM; Boland MV
    AJR Am J Roentgenol; 2015 Nov; 205(5):W512-8. PubMed ID: 26496573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features associated with lesions other than pituitary adenoma in patients with an optic chiasmal syndrome.
    Mejico LJ; Miller NR; Dong LM
    Am J Ophthalmol; 2004 May; 137(5):908-13. PubMed ID: 15126157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting impairment of central vision from dimensions of the optic chiasm in patients with pituitary adenoma.
    Carrim ZI; Reeks GA; Chohan AW; Dunn LT; Hadley DM
    Acta Neurochir (Wien); 2007 Mar; 149(3):255-60; discussion 260. PubMed ID: 17273885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for the development of visual loss in patients with pituitary macroadenomas and for visual recovery after optic pathway decompression.
    Monteiro ML; Zambon BK; Cunha LP
    Can J Ophthalmol; 2010 Aug; 45(4):404-8. PubMed ID: 20648089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and ophthalmologic findings of pituitary adenoma in Korean patients.
    Kim TG; Jin KH; Kang J
    Int Ophthalmol; 2019 Jan; 39(1):21-31. PubMed ID: 29274021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transsphenoidal Microneurosurgery. Part 4: Neuroophthalmological cure in pituitary adenoma].
    Oi S; Ciric IS
    No Shinkei Geka; 1982 Nov; 10(11):1183-7. PubMed ID: 7155292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chiasma syndrome in acromegalic patients--correlation of neuroradiologic and neuroophthalmologic findings.
    Gnjidić Z; Iveković R; Rumboldt Z; Malenica M; Vizner B; Berković M
    Coll Antropol; 2002 Dec; 26(2):601-8. PubMed ID: 12528288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pituitary adenoma revealed by Traquair's syndrome].
    Candiloros H; Saudax E; George JL; Leclere J; Hartemann P
    Ann Endocrinol (Paris); 1992; 53(5-6):236-40. PubMed ID: 1340691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual acuity and pattern of visual field loss at presentation in pituitary adenoma.
    Ogra S; Nichols AD; Stylli S; Kaye AH; Savino PJ; Danesh-Meyer HV
    J Clin Neurosci; 2014 May; 21(5):735-40. PubMed ID: 24656736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiologic presentation of pituitary adenoma.
    Baruffi DJ; Thompson KR
    Optom Vis Sci; 2012 Nov; 89(11):e56-64. PubMed ID: 23096493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humphrey visual field analysis, visual field defects, and ophthalmic findings in patients with macro pituitary adenoma.
    Gedik S; Gur S; Atalay B; Colak M; Altinors N; Akova YA
    Saudi Med J; 2007 Sep; 28(9):1380-4. PubMed ID: 17768464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual disturbances in patients with pituitary adenoma.
    Ikeda H; Yoshimoto T
    Acta Neurol Scand; 1995 Aug; 92(2):157-60. PubMed ID: 7484065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scotomatous defects in the central visual field in pituitary adenomas.
    Sugita K; Sato O; Hirota T; Tsugane R; Kageyama N
    Neurochirurgia (Stuttg); 1975 Sep; 18(5):155-62. PubMed ID: 172816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative magnetic resonance imaging and early prognosis for vision after transsphenoidal surgery for sellar lesions.
    Berkmann S; Fandino J; Zosso S; Killer HE; Remonda L; Landolt H
    J Neurosurg; 2011 Sep; 115(3):518-27. PubMed ID: 21639700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Chiasmal Compression Index: An Integrative Assessment Tool for Visual Disturbances in Patients with Pituitary Macroadenomas.
    Avraham E; Azriel A; Melamed I; Alguayn F; Al Gawad Siag A; Aloni E; Sufaro Y
    World Neurosurg; 2020 Nov; 143():e44-e50. PubMed ID: 32562903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of optical coherence tomography in the detection of pituitary adenoma.
    Johansson C; Lindblom B
    Acta Ophthalmol; 2009 Nov; 87(7):776-9. PubMed ID: 18771481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decision Making for Patients With Concomitant Pituitary Macroadenoma and Ophthalmologic Comorbidity: A Clinical Controversy.
    Hajiabadi M; Alimohamadi M; Fahlbusch R
    World Neurosurg; 2015 Jul; 84(1):147-53. PubMed ID: 25769486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.